|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 4, 605-612, Copyright © 1990 by European Association for Cardio-thoracic Surgery
U Eberlein, J von der Emde, J Rein and HD Esperer
One thousand six hundred and sixty-eight consecutive patients who underwent
isolated mitral valve replacement (MVR) from 1963 to 1984 were evaluated
retrospectively. Thromboembolism occurred with a linearised rate of 2.5%
+/- 0.2%/patient-year (PY) for Starr-Edwards disc prosthesis Model 6520,
2.4% +/- 0.3%/PY for Bjork-Shiley plane prosthesis, 3.0% +/- 0.8%/PY for
Bjork-Shiley convexo-concave 60 degrees prosthesis, 3.0% +/- 0.8%/PY for
St. Jude Medical prosthesis and 3.4% +/- 0.5%/PY for Carpentier-Edwards
tissue valve without the differences reaching significance. In the SJM
group, the incidence of thromboembolism was significantly higher (P less
than 0.025) in smaller sizes (less than M29) probably due to a more
turbulent flow. The linearised rate for major haemorrhage was 1.6% +/-
0.1%/PY. Twenty- three percent of the thromboembolic and 18% of the
bleeding events were fatal. Sixty-eight percent of the emboli involved the
central nervous system and bleeding apart from fatalities was predominantly
non- cerebral (81%). Whereas thromboembolism was a time-related event with
more than twice as high a risk in the first postoperative year (4.2% +/-
0.5% vs. 1.7% +/- 0.8%, P less than 0.01), bleeding occurred with a
constant rate over time (0.9% +/- 0.4%). Adequacy of anticoagulation was an
important risk factor for postoperative embolism with the prothrombin time
(PT) exceeding the therapeutic range in 65% of all events. A preoperative
history of embolism was the only additional patient-related risk factor for
postoperative embolism (18.3% vs. 9.6%, P less than 0.001). In 30% of all
haemorrhage, the PT was below 15%.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Thromboembolic and bleeding complications after mitral valve replacement
Department of Cardiac Surgery, University of Erlangen-Nurnberg, FRG.
This article has been cited by other articles:
![]() |
R. R. Moss, K. H. Humphries, M. Gao, C. R. Thompson, J. G. Abel, G. Fradet, and B. I. Munt Outcome of Mitral Valve Repair or Replacement: A Comparison by Propensity Score Analysis Circulation, September 9, 2003; 108(90101): II-90 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Cesnjevar, R. Feyrer, F. Walther, F. O. Mahmoud, Y. Lindemann, and J. von der Emde High-risk mitral valve replacement in severe pulmonary hypertension--30 years experience Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 344 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
L-F. Debetaz, P. Ruchat, M. Hurni, A. Fischer, F. Stumpe, H. Sadeghi, G. van Melle, and J-J. Goy ST. JUDE MEDICAL VALVE PROSTHESIS: AN ANALYSIS OF LONG-TERM OUTCOME AND PROGNOSTIC FACTORS J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 134 - 148. [Abstract] [Full Text] |
||||
![]() |
M. H. Eckman, H. J. Levine, and S. G. Pauker Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy N. Engl. J. Med., September 2, 1993; 329(10): 696 - 702. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |